PDF(992 KB)
Serum levels of insulin-like growth factor-1 in neonates with hyperbilirubinemia
LIU Fang, TU Wei-Qi, SONG Xia, YUAN Er-Wei, LI Huai-Ying
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (05) : 357-360.
PDF(992 KB)
PDF(992 KB)
Serum levels of insulin-like growth factor-1 in neonates with hyperbilirubinemia
OBJECTIVE: Insulin-like grouth factor-1 (IGF-1) is polypetide hormone that has demonstrated effects on neural cells. Up to now, there is few reports about the relation between serum IGF-1 and brain damage in neonates with hyperbilirubinemia. This study explored the potential role of serum IGF-1 in neonatal hyperbilirubinemia. METHODS: Serum levels of IGF-1 were measured using ECLIA in 57 term neonates with hyperbilirubinemia and 25 normal term neonates. Meanwhile, total serum bilirubin (TSB), unconjugated bilirubin (USB) and serum albumin (ALB) contents were measured by the automatic biochemistry analyzer and the ratio of USB/ALB (B/A) was calculated. The hyperbilirubinemia group was classified into three subgroups based on serum TSB levels: mild (221-256 μmol/L), moderate (257-342 μmol/L) and severe (>342 μmol/L). Serum TSB levels in the 25 normal neonates were less than 85 μmol/L (control group). NBNA was performed on the day of serum sample collection. RESULTS: Serum IGF-1 levels in the mild, moderate and severe hyperbilirubinemia groups (39.38±8.42, 30.77±4.65 and 26.34±2.05 ng/L, respectively) were obviously lower than those in the control group (50.16±15.73 ng/L) (P<0.01). There were significant differences among the three hyperbilirubinemia subgroups in serum IGF-1 levels (P<0.01). Mean NBNA scores in the mild, moderate and severe hyperbilirubinemia groups (35.01±2.26, 32.45±2.74 and 26.77±5.02, respectively) were significantly lower than those in the control group (38.24±0.78) (P<0.01). Significant differences in the NBNA scores were noted among the three hyperbilirubinemia subgroups (P<0.01). Serum IGF-1 levels were positively correlated to NBNA scores (r=0.603, P<0.01) and negatively correlated to the ratio of B/A (r=-0.483, P<0.01). CONCLUSIONS: Serum IGF-1 levels decreased obviously in neonates with hyperbilirubinemia and correlated to the severity of disease. IGF-1 might be associated with bilirubin-induced brain damage.［Chin J Contemp Pediatr, 2009, 11 (5):357-360］
Insulin-like growth factor-1 / Hyperbilirubinemia / Brain damage / Neonate
［1］杨晓梅,高传化,陆洋. 新生儿高胆红素血症与多脏器损害的关系探讨［J］.中国小儿急救医学, 2006, 13(3):268-269.
［2］Le Roith D. The insulin-like growth factors system［J］. Exp Diabesity Res, 2003, 4(4):205-212.
［3］董淑兰,华青,于爱华,杨玉英,张玉英.新生儿高胆红素血症的远期随访研究［J］.中国实用儿科杂志, 1999, 14(2):87-88.
［4］田巧红,陈昌辉. 新生儿胆红素脑病发病机制与防治［J］. 实用医院临床杂志, 2005, 2(3):84-85.
［5］Guan J, Skinner SJ, Beilharz EJ. The movement of IGF-1 into the brain parenchyma after hypoxic-ischaemic injury［J］. Neuroreport, 1996, 7(2):632-636.
［6］Lesort M, Johnson GV. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons［J］. Neuroscience, 2000, 99(2):305-316.
［7］Guan J, Beilharz EJ, Skinner SJ, Williams CE, Gluckman PD. Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemic brain injury［J］. Brain Res, 2000, 853(2):163-173.
［8］Brywe KG, Mallard C, Gustavsson M, Hedtjarn M, Leverin AL, Wang X, et al. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?［J］. Eur J Neurosci, 2005, 21(6):1489-1502.
［9］Wood TL, Loladze V, Altieri S, Gangoli N, Levison SW, Brywe KG, et al. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage［J］. Dev Neurosci, 2007, 29(4-5):302310.
［10］敖当,黄宇戈,陈铭珍,揭育丽.胰岛素样生长因子-Ⅰ在新生儿缺氧缺血性脑病时血液中水平变化及意义［J］.临床儿科杂志, 2003, 21(7):408-409.
［11］Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM.Toward understanding kernicterus:a challenge to improve the management of jaundiced newborns［J］.Pediatrics, 2006, 117(2): 474-485.
［12］张亚京,张爱平,王鑫,陈欣,黄学英,刘志晶,等.新生儿高胆红素血症对其神经行为及预后的影响［J］.实用儿科临床杂志,2003, 18(12):989-990.
［13］王晓安,方妍彤,朱银燕,王晓芳.85例高胆红素血症新生儿行为神经测定［J］.浙江实用医学, 2006, 11(6):395-405.
［14］陈艳霞,王家勤,许建文. 新生儿高胆红素血症行为神经测定及婴幼儿期智能发育随访［J］.实用儿科临床杂志, 2007, 22(14):1079-1080.
［15］潘新年,杨广林,黄跃.足月新生儿高间接胆红素血症与中枢损害关系的探讨［J］.中国当代儿科杂志, 2006, 8(5):429-430.
［16］Wang JM, Hayashi T, Zhang MR. Reduction of ischemic brain injury topical application of insulin-like growth factor-1after transient middle cerebral artery occlusion in rats［J］. Brain Res, 2000, 859(2):381-385.
［17］万忠和, 肖昕. 血清胰岛素样生长因子Ⅰ及生长激素与新生儿缺氧缺血性脑病的关系［J］ 中国当代儿科杂志, 2007, 9(1):22-24.
